ESR2 Drives Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer and Tumorigenesis In Vivo

ESR2 Drives Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer and Tumorigenesis In Vivo

Estrogen receptors (ERs) have pivotal roles in the development and progression of triple-negative breast cancer (TNBC). Interactions among cancer cells and tumor microenvironment are orchestrated by the extracellular matrix that is rapidly emerging as prominent contributor of fundamental processes o...

Full description

Bibliographic Details
Main Authors: Zoi Piperigkou, Anastasios Koutsandreas, Marco Franchi, Vasiliki Zolota, Dimitrios Kletsas, Alberto Passi, Nikos K. Karamanos
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
breast cancer
ESR2
estrogen receptor beta
tumorigenesis
extracellular matrix
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.917633/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.917633/full

Similar Items